Live Breaking News & Updates on Axsome Therapeutic Inc

Stay updated with breaking news from Axsome therapeutic inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sunosi Improving Cognitive Function in OSA Patients with EDS

Sunosi (solriamfetol) is demonstrating improvement in cognitive function in patients with excessive daytime sleepiness associated with OSA. ....

United States , Eileen Leary , Samantha Floam , Drug Administration , American Society Of Clinical Psychopharmacology , Axsome Therapeutic Inc , American Society , Clinical Psychopharmacology , Annual Meeting , Cognitive Function , Cognitive Impairment Associated , Excessive Daytime Sleepiness , Obstructive Sleep Apnea , Daytime Sleepiness , Real World Study , Potential Mechanisms , Gregory Parks ,